Allied Private Wealth »

Design Therapeutics shares owned by Allied Private Wealth

Quarter-by-quarter ownership of Design Therapeutics (DSGN) shares owned by Allied Private Wealth from 13F filings

Historical chart of Allied Private Wealth investment in Design Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Design Therapeutics held by Allied Private Wealth consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Design Therapeutics by Allied Private Wealth

Quarter filed Position value Share count Share price at filing
2026-06-30 $13k 880 15.28

More positions owned by Allied Private Wealth

Apple Stock (AAPL)
Microsoft Corp Stock (MSFT)
Vanguard S&p 500 Etf Etf (VOO)
Capital Group Dividend Value Etf Etf (CGDV)
Amazon Stock (AMZN)
Nvidia Corporation Stock (NVDA)
Avantis International Equity Etf Etf (AVDE)
Berkshire Hathaway Inc Del Cl B Stock (BRK.B)
Ishares 0-3 Month Treasury Bond Etf Etf (SGOV)
American Century Diversified Municipal Bond Etf Etf (TAXF)
Janus Henderson Small/mid Cap Growth Alpha Etf Etf (JSMD)
Ishares U.s. Technology Etf Etf (IYW)
Fidelity Msci Information Technology Index Etf Etf (FTEC)
Blackstone Stock (BX)
Alphabet Inc Cap Stk Cl C Stock (GOOG)

View all positions for Allied Private Wealth

Top funds holding Design Therapeutics

Sr One Capital Management
RA Capital Management
Point72 Asset Management
Baker Bros. Advisors
BlackRock
Logos Global Management
Driehaus Capital Management
Vivo Capital
Almitas Capital
Vanguard Capital Management
Woodline Partners
Trails Edge Capital Partners
FMR
Kynam Capital Management
Geode Capital Management

View all funds holding Design Therapeutics